Allegro Diagnostics is your global leader in the diagnosis of epithelial diseases by providing earlier, more accurate information to clinicians and patients about patient health.

Allegro Diagnostics was founded on three basic principles that have been developed and refined by the research of our founders:

• The molecular "field of injury" extends beyond cells that manifest the disease of interest.
• Pure populations of epithelial cells from the field of injury need to be easily accessible.
• Global gene expression in these epithelial cells provides clinically important diagnostic, prognostic, and pathogenic information about the disease of interest.